Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas.
Wang YX, Wu H, Ren Y, Lv S, Ji C, Xiang D, Zhang M, Lu H, Fu W, Liu Q, Yan Z, Ma Q, Miao J, Cai R, Lan X, Wu B, Wang W, Liu Y, Wang DZ, Cao M, He Z, Shi Y, Ping Y, Yao X, Zhang X, Zhang P, Wang JM, Wang Y, Cui Y, Bian XW.
Wang YX, et al.
Signal Transduct Target Ther. 2022 Mar 11;7(1):72. doi: 10.1038/s41392-022-00890-7.
Signal Transduct Target Ther. 2022.
PMID: 35273141
Free PMC article.